(May 20, 2019, 11:47 AM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on May 20 ruled that a judge and not a jury should decide if the Food and Drug Administration would have rejected a warning about the risk of femur fractures from the osteoporosis drug Fosamax (Merck Sharp & Dohme Corp. v. Doris Albrecht, et al., No. 17-290, U.S. Sup.)....